Search filters

List of works by Jean-Paul Guastalla

A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1159 patients

scientific article published on 27 October 2005

A comparative study of exemestane versus anastrozole in patients with postmenopausal breast cancer with visceral metastases

scientific article

A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study

scientific article published on 7 February 2004

A phase 2 trial of whole-brain radiotherapy combined with intravenous chemotherapy in patients with brain metastases from breast cancer

scientific article

A phase II study of an oxaliplatin/vinorelbine/5-fluorouracil combination in patients with anthracycline-pretreated and taxane-pretreated metastatic breast cancer

scientific article published on 01 October 2006

A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study

scientific article published on 5 July 2007

Adjuvant docetaxel for node-positive breast cancer

scientific article published in June 2005

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial.

scientific article

Adjuvant use of anastrozole in breast cancer

scientific article published in April 2004

Are antiangiogenic antibodies universal for solid tumor?

scientific article published in July 2007

Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case series.

scientific article published in May 2009

Bevacizumab plus microtubule targeting agents in heavily pre-treated ovarian cancer patients: a retrospective study.

scientific article published in October 2011

Body weight change in women receiving adjuvant chemotherapy for breast cancer: a French prospective study.

scientific article published on 26 August 2009

Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial ⬇️

scientific article published on December 17, 2012

Cervix cancer and corpus cancer of the uterus

scientific article published on 01 December 2011

Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994–1998 and 2003–2006

scientific article published on 24 December 2010

Cyclooxygenase 2 and breast cancer. From biological concepts to clinical trials

scientific article published in May 2004

Cyclooxygenase 2 and breast cancer. From biological concepts to therapeutic trials

scientific article published in May 2004

Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer

scientific article published on 01 November 2004

Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial

scientific article published on 25 October 2004

Does a homeopathic medicine reduce hot flushes induced by adjuvant endocrine therapy in localized breast cancer patients? A multicenter randomized placebo-controlled phase III trial

scientific article published on 07 September 2018

Efficacy of Trastuzumab in Routine Clinical Practice and After Progression for Metastatic Breast Cancer Patients: The Observational Hermine Study ⬇️

scientific article published on July 29, 2010

Efficacy of epoetin alfa in a retrospective non-stratified subgroup analysis of a breast cancer cohort receiving non-platinum chemotherapy

scientific article published in September 2004

Epirubicin and paclitaxel (EPI-TAX regimen) for advanced ovarian cancer after failure of platinum-containing regimens

scientific article published in March 2003

Final Results of ERASME-4: A Randomized Trial of First-Line Docetaxel plus either Capecitabine or Epirubicin for Metastatic Breast Cancer ⬇️

scientific article published on July 6, 2011

First epidemiological data from the French Trophoblastic Disease Reference Center

scientific article

First-line endocrine therapy alone could be a reasonable treatment option for hormone-positive, HER2-positive metastatic breast cancer.

scientific article

HER2 status in ovarian carcinomas: a multicenter GINECO study of 320 patients

scientific article

Impact of chemotherapy regimens prior to endocrine therapy: Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial

scientific article published on 01 August 2006

Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas

scientific article published on 23 June 2009

Mechanisms of resistance to endocrine therapies for breast cancer

scientific article

Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity.

scientific article

Motivations of patients seeking supportive care for cancer from physicians prescribing homeopathic or conventional medicines: results of an observational cross-sectional study

scientific article published on 24 October 2016

Multidisciplinarity and medical decision, impact for patients with cancer: sociological assessment of two tumour committees' organization

scientific article published in April 2012

New developments in treatment of ovarian carcinoma: focus on trabectedin

scientific article

Phase I study of pegylated liposomal doxorubicin in combination with ifosfamide in pretreated ovarian cancer patients

scientific article published on 01 August 2006

Randomized parallel study of doxorubicin plus paclitaxel and doxorubicin plus cyclophosphamide as neoadjuvant treatment of patients with breast cancer

scientific article published on 01 December 2004

Trebananib (AMG 386) plus weekly paclitaxel with or without bevacizumab as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer: A phase 2 randomized study

scientific article published on 5 March 2015

What is the best protocol of single-agent methotrexate chemotherapy in nonmetastatic or low-risk metastatic gestational trophoblastic tumors? A review of the evidence

scientific article

[Adjuvant therapies: the example of breast cancer]

scientific article published on 01 April 2008

[Adjuvant treatments in breast cancer: interest of completion of axillary dissection in case of micrometastases or isolated tumor cells in sentinel lymph node]

scientific article published on 01 April 2012

[Advanced ovarian cancer: a need for redefining therapeutic objectives and strategy]

scientific article published on 01 November 2005

[Anemia and chemotherapy]

scientific article published on 01 April 2003

[Antihormonal therapy in breast cancer and mTOR inhibitors]

scientific article published on 01 December 2011

[Neoadjuvant chemotherapy and ovarian cancer]

scientific article published on 01 July 2006

[Prognostic factors for febrile neutropenia].

scientific article

[Standards, Options and Recommendations for the management of invasive cervical cancer patients (non metastastic)]

scientific article published on 01 April 2003

Paulina is supported by:

About Paulina

Help